Regorafenib

Grey

Brand Name(s):Stivarga

Indication:Cancer -Hepatocellular carcinoma (HCC)

Rationale:1

Considered:Sep-17

Review Date:Apr-23

Comments:
NICE TA514
Regorafenib for previously treated advanced hepatocellular carcinoma
Mar-18